WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001083774) NOVEL MUTATED FORM OF ARGININE DEIMINASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/083774    International Application No.:    PCT/US2001/014116
Publication Date: 08.11.2001 International Filing Date: 02.05.2001
Chapter 2 Demand Filed:    07.11.2001    
IPC:
C12N 9/14 (2006.01)
Applicants: PHOENIX PHARMACOLOGICS, INC. [US/US]; Doctors Park Suite 402 1517 Nicholasville Road Lexington, KY 40503 (US) (For All Designated States Except US).
ENSOR, Charles, Mark [US/US]; (US) (For US Only).
HOLTSBERG, Frederick, Wayne [US/US]; (US) (For US Only).
CLARK, Mike, A. [US/US]; (US) (For US Only)
Inventors: ENSOR, Charles, Mark; (US).
HOLTSBERG, Frederick, Wayne; (US).
CLARK, Mike, A.; (US)
Agent: ELDERKIN, Dianne, B.; Woodcock Washburn LLP 46th floor One Liberty Place Philadelphia, PA 19103 (US)
Priority Data:
09/564,559 04.05.2000 US
Title (EN) NOVEL MUTATED FORM OF ARGININE DEIMINASE
(FR) NOUVELLE FORME MUTANTE D'ARGININE DEIMINASE
Abstract: front page image
(EN)The present invention discloses arginine deiminase that is genetically modified for more efficient manufacturing and processing. The present invention discloses recombinant DNA molecules and vectors and other therapeutic and pharmaceutical compositions. The present invention also discloses methods for preparing modified arginine deiminase as well as methods of treating cancer and other disease states using modified arginine deiminase.
(FR)La présente invention concerne de l'arginine deiminase génétiquement modifiée en vue d'une fabrication et d'un traitement plus efficaces. L'invention concerne également des vecteurs et des molécules d'ADN recombinés et autres compositions thérapeutiques et pharmaceutiques. L'invention concerne en outre des procédés de préparation de l'arginine deiminase ainsi que des méthodes de traitement du cancer et autres états pathologiques au moyen de l'arginine deiminase modifiée.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)